InsiderTrades

Form 4 for ABBV AbbVie

Accepted 2021-12-08 00:00:00 ET · period of report 2021-12-06 · accession 0001179110-21-010695 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-12-08 2021-12-06 ABBV RICHMOND TIMOTHY J. EVP, Chief HR Off M - OptEx $58.88 +50.4K 50.4K New +$2.96M
D 2021-12-08 2021-12-06 ABBV RICHMOND TIMOTHY J. EVP, Chief HR Off S - Sale+OE $120.00 -50.4K 0 -100% -$6.04M
D 2021-12-08 2021-12-06 ABBV RICHMOND TIMOTHY J. EVP, Chief HR Off M - OptEx $0.00 -50.4K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.01 par value 2021-12-06 M A 50,350 $58.88 50,350 D — —
2 Common Common Stock, $0.01 par value 2021-12-06 S D 50,350 $120.00 0 D — —
3 Derivative Option (Right to buy) 2021-12-06 M D 50,350 $0.00 0 D $58.88 · 2016-02-19 to 2025-02-18 50,350 Common stock (F1) Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.